Advertisement

Topics

BiPar Sciences, Inc. Company Profile

04:03 EDT 17th October 2017 | BioPortfolio

BiPar Sciences is a drug development company with a therapeutic focus on exploring novel mechanisms of action in oncology. The lead development program is based on DNA repair, specifically with poly ADP-ribose polymerase (PARP) inhibitors. The lead product within that program is BSI-201, a platform drug with the potential to be a superior new treatment across a range of tumor types, both as monotherapy and in combination with chemotherapy. The company is currently testing BSI-201 in a range of Phase 2 trials, including studies in breast, uterine, brain and ovarian cancers.


News Articles [224 Associated News Articles listed on BioPortfolio]

sanofi-aventis’ New Direction

Since Chris Viehbacher joined sanofi-aventis as CEO his aim has been to get the company recognised as a global healthcare company and not solely as a producer of vaccines. Jean-Claude Muller, Senior V...

CV Sciences, Inc. Announces Webcast for Investor Update Call

LAS VEGAS, NV--(Marketwired - September 11, 2017) -CV Sciences, Inc., ( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we") Read more...

CV Sciences, Inc. Announces Commencement of IND preparation immediately following Pre-IND ...

LAS VEGAS, NV--(Marketwired - June 19, 2017) -CV Sciences, Inc. ( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we"), today Read more...

CV Sciences, Inc. to Present at MJAC2017 InvestorsHub International Cannabis Conference

LAS VEGAS, NV--(Marketwired - August 28, 2017) -CV Sciences, Inc. ( OTCQB : CVSI) ("CV Sciences," "our" or "we"), is pleased to Read more...

CV Sciences, Inc. Highlights Recent Research Showing Cannabidiol May Reduce Relapses in ...

LAS VEGAS, NV--(Marketwired - August 15, 2017) -CV Sciences, Inc.( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we") highlighted Read more...

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...

Lords Committee Launches New Inquiry into Life Sciences and the Industrial Strategy

The House of Lords Science and Technology Committee invites contributions to its new inquiry - Life Sciences and the Industrial Strategy. The Government set out in its Industrial Strategy Green Paper ...

Tauriga Sciences, Inc. Obtains Stockholders Approval to Increase its Authorized Common Stock at Special Shareholder Meeting

NEW YORK, NY -- (Marketwired) -- 06/28/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of life sciences businesses and technologies, today annou...

Clinical Trials [152 Associated Clinical Trials listed on BioPortfolio]

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir and Ledipasvir from M...

Companies [1018 Associated Companies listed on BioPortfolio]

BiPar Sciences, Inc.

BiPar Sciences is a drug development company with a therapeutic focus on exploring novel mechanisms of action in oncology. The lead development program is based on DNA repair, specifically with po...

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

T.A. Sciences

T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

More Information about "BiPar Sciences, Inc." on BioPortfolio

We have published hundreds of BiPar Sciences, Inc. news stories on BioPortfolio along with dozens of BiPar Sciences, Inc. Clinical Trials and PubMed Articles about BiPar Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BiPar Sciences, Inc. Companies in our database. You can also find out about relevant BiPar Sciences, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record